LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Safety aspects of microorganisms deliberately released into the environment

19/07/2024
LITERATURE REVIEW

Safety aspects of microorganisms deliberately released into the environment

(Alexandra Lensch, Hanna Abbas Lindfors, Elke Duwenig, Tobias Fleischmann, Carsten Hjort, Sirpa O. K¨arenlampi, Lucie McMurtry, Emily-Denise Melton, Mikael Rørdam Andersen, Ryan Skinner, Markus Wyss, Richard van Kranenburg)

ABSTRACT

Microorganisms are used in a variety of sectors, including food and feed production, agricultural or environmental applications, and can be optimized for efficacy, safety and sustainability using modern biotechnology techniques. In the EU, genetically modified microorganisms (GMMs) are typically used as production organisms for food and feed products, including enzymes, amino acids, vitamins, flavourings, and oligosaccharides under the Contained Use Directive. Applications involving live GMMs would fall under the Deliberate Release Directive. However, its relevant regulations and guidelines are so far not supporting the access to market of GMMs. In this literature review, we examine what is already known or can be inferred about the safety of microorganisms deliberately released into the environment across sectors. We conclude that there is sufficient evidence supporting the establishment of a European framework for the risk assessment of GMMs deliberately released into the environment, which would enable timely market access for live GMM products.

Read the full article below.

Safety aspects of microorganisms deliberately released into theenvironmentDownload
Share
Francesca Degli Agostini
Francesca Degli Agostini

Related posts

07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
26/06/2025

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.